New flavored chemo drink aims to ease treatment for kids with hard-to-treat cancers
Disease control
Ongoing
This early-phase study tests a flavored, drinkable version of the chemotherapy drug irinotecan (VAL-413) combined with another drug (temozolomide) in children and young adults up to age 30 whose solid tumors have come back. The main goal is to find the safest dose and see how the…
Phase: PHASE1 • Sponsor: Valent Technologies, LLC • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC